Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs

Kampourakis, Kostas; Vayena, Effy; Mitropoulou, Christina; van Schaik, Ron; Cooper, David; Borg, Joseph; Patrinos, George

doi:10.1002/embr.201438641

K. Kampourakis (Kostas), E. Vayena (Effy), C. Mitropoulou (Christina), R.H.N. van Schaik (Ron), D.N. Cooper (David), J. Borg (Joseph) and G.P. Patrinos (George)

2014

Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs

E M B O Reports , Volume 15 - Issue 5 p. 472- 476

Recent advances in genomics and sequencing technology herald the advent of pharmacogenomics in routine clinical practice. Yet, while science and technology have progressed rapidly, legal, social and ethical challenges remain to be resolved.

Additional Metadata
Persistent URL	doi.org/10.1002/embr.201438641, hdl.handle.net/1765/59401
Journal	E M B O Reports
Organisation	Department of Clinical Chemistry
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Kampourakis, K., Vayena, E., Mitropoulou, C., van Schaik, R., Cooper, D., Borg, J., & Patrinos, G. (2014). Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs. E M B O Reports, 15(5), 472–476. doi:10.1002/embr.201438641

Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs

Publication

Publication

About

Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs

Publication

Publication

Workflow

Workflow

Add Content